OBJECTIVES: To determine the involvement of the midbrain and hindbrain (MHB) in the groups of classic (cLIS), variant (vLIS), and cobblestone complex (CBSC) lissencephalies and to determine whether a correlation exists between the cerebral malformation and the MHB abnormalities. METHODS: MRI scans of 111 patients (aged 1 day to 32 years; mean 5 years 4 months) were retrospectively reviewed. After reviewing the brain involvement on MRI, the cases were reclassified according to known mutation (LIS1, DCX, ARX, VLDLR, RELN, MEB, WWS) or mutation phenotype (LIS1-P, DCX-P, RELN-P, ARX-P, VLDLR-P) determined on the basis of characteristic MRI features. Abnormalities in the MHB were then recorded. For each structure, a score was assigned, ranging from 0 (normal) to 3 (severely abnormal). The differences between defined groups and the correlation between the extent of brain agyria/pachygyria and MHB involvement were assessed using Kruskal-Wallis and chi(2) McNemar tests. RESULTS: There was a significant difference in MHB appearance among the three major groups of cLIS, vLIS, and CBSC. The overall score showed a severity gradient of MHB involvement: cLIS (0 or 1), vLIS (7), and CBSC (11 or 12). The extent of cerebral lissencephaly was significantly correlated with the severity of MHB abnormalities (p = 0.0029). CONCLUSION: Our study focused on posterior fossa anomalies, which are an integral part of cobblestone complex lissencephalies but previously have not been well categorized for other lissencephalies. According to our results and the review of the literature, we propose a new classification of human lissencephalies.
OBJECTIVES: To determine the involvement of the midbrain and hindbrain (MHB) in the groups of classic (cLIS), variant (vLIS), and cobblestone complex (CBSC) lissencephalies and to determine whether a correlation exists between the cerebral malformation and the MHB abnormalities. METHODS: MRI scans of 111 patients (aged 1 day to 32 years; mean 5 years 4 months) were retrospectively reviewed. After reviewing the brain involvement on MRI, the cases were reclassified according to known mutation (LIS1, DCX, ARX, VLDLR, RELN, MEB, WWS) or mutation phenotype (LIS1-P, DCX-P, RELN-P, ARX-P, VLDLR-P) determined on the basis of characteristic MRI features. Abnormalities in the MHB were then recorded. For each structure, a score was assigned, ranging from 0 (normal) to 3 (severely abnormal). The differences between defined groups and the correlation between the extent of brain agyria/pachygyria and MHB involvement were assessed using Kruskal-Wallis and chi(2) McNemar tests. RESULTS: There was a significant difference in MHB appearance among the three major groups of cLIS, vLIS, and CBSC. The overall score showed a severity gradient of MHB involvement: cLIS (0 or 1), vLIS (7), and CBSC (11 or 12). The extent of cerebral lissencephaly was significantly correlated with the severity of MHB abnormalities (p = 0.0029). CONCLUSION: Our study focused on posterior fossa anomalies, which are an integral part of cobblestone complex lissencephalies but previously have not been well categorized for other lissencephalies. According to our results and the review of the literature, we propose a new classification of humanlissencephalies.
Authors: S E Hong; Y Y Shugart; D T Huang; S A Shahwan; P E Grant; J O Hourihane; N D Martin; C A Walsh Journal: Nat Genet Date: 2000-09 Impact factor: 38.330
Authors: Cheryl Longman; Martin Brockington; Silvia Torelli; Cecilia Jimenez-Mallebrera; Colin Kennedy; Nofal Khalil; Lucy Feng; Ravindra K Saran; Thomas Voit; Luciano Merlini; Caroline A Sewry; Susan C Brown; Francesco Muntoni Journal: Hum Mol Genet Date: 2003-09-09 Impact factor: 6.150
Authors: D Beltran-Valero de Bernabé; T Voit; C Longman; A Steinbrecher; V Straub; Y Yuva; R Herrmann; J Sperner; C Korenke; C Diesen; W B Dobyns; H G Brunner; H van Bokhoven; M Brockington; F Muntoni Journal: J Med Genet Date: 2004-05 Impact factor: 6.318
Authors: M Severino; A E M Allegri; A Pistorio; B Roviglione; N Di Iorgi; M Maghnie; A Rossi Journal: AJNR Am J Neuroradiol Date: 2014-04-24 Impact factor: 3.825
Authors: Nataliya Di Donato; Sara Chiari; Ghayda M Mirzaa; Kimberly Aldinger; Elena Parrini; Carissa Olds; A James Barkovich; Renzo Guerrini; William B Dobyns Journal: Am J Med Genet A Date: 2017-04-25 Impact factor: 2.802
Authors: Farid Radmanesh; Ahmet Okay Caglayan; Jennifer L Silhavy; Cahide Yilmaz; Vincent Cantagrel; Tarek Omar; Başak Rosti; Hande Kaymakcalan; Stacey Gabriel; Mingfeng Li; Nenad Sestan; Kaya Bilguvar; William B Dobyns; Maha S Zaki; Murat Gunel; Joseph G Gleeson Journal: Am J Hum Genet Date: 2013-03-07 Impact factor: 11.025
Authors: Katherine G Meilleur; Kristen Zukosky; Livija Medne; Pierre Fequiere; Nina Powell-Hamilton; Thomas L Winder; Abdulaziz Alsaman; Ayman W El-Hattab; Jahannaz Dastgir; Ying Hu; Sandra Donkervoort; Jeffrey A Golden; Ralph Eagle; Richard Finkel; Mena Scavina; Ian C Hood; Lucy B Rorke-Adams; Carsten G Bönnemann Journal: J Neuropathol Exp Neurol Date: 2014-05 Impact factor: 3.685